3 chapters across the catalog
Moderna abruptly halted its mRNA vaccine clinical trial for Respiratory Syncytial Virus (RSV) in children after data indicated the vaccine might worsen the disease. The FDA disclosed that vaccinated children in the trial experienced severe RSV at rates up to three times higher than the placebo group.
Immunocompromised Patients, Vaccine Efficacy Questions
CDC Director Dr. Rochelle Walensky admitted that emerging data suggests COVID-19 vaccines may not work effectively for immunocompromised individuals, such as those undergoing chemotherapy or transplant recipients. She advised these patients to consult their physicians and continue wearing masks despite being fully vaccinated.
Media Ad Buys, Pharmaceutical Profit Models, Vaccine Failure Backstops
A theory is proposed that pharmaceutical companies are shifting toward a recurring revenue model by normalizing the need for annual COVID-19 shots. Additionally, the discussion suggests that the "variant" narrative serves as a convenient explanation or "backstop" for health officials if the initial vaccine rollout fails to prevent infections.
